Menopause & perimenopause

Uterine hyperplasia — References & further reading

American College of Obstetricians & Gynecologists Committee on Gynecologic Practice. 2006. ACOG committee opinion. No. 336: Tamoxifen and uterine cancer. Obstet. Gynecol., 107 (6), 1475–1478.

American College of Obstetricians & Gynecologists Committee on Gynecologic Practice. 2006. ACOG committee opinion. No. 337: Noncontraceptive uses of the levonorgestrel intrauterine system. Obstet. Gynecol., 107 (6), 1479–1482.

Speroff, L., et al. 1999. Clinical gynecologic endocrinology and infertility, 6th ed. Philadelphia: Lippincott, Williams & Wilkins.

 


Return to:

Uterine hyperplasia

 

Original Publication Date: 08/16/2006
Last Modified: 02/16/2010
Principal Author: Marcy Holmes, NP, Certified Menopause Clinician

Newsletter
Your Personal Program
Your Stories

"I definitely won, and I will never go back to HRT!"

Deselie is a very active, grab-life-by-the-horns business owner who came to us at age 57 with lots of symptoms, despite being on hormone replacement therapy (HRT). The high stress in her life, and an intolerance for soy, made stopping HRT more of a challenge. But she was up to it!

Read this Story | All Stories



Questions? Call us at

1-800-798-7902

We're here to listen and help.